Commentary · 27 May 2026
Conference abstractPublished 12 Oct 2017
CORRELATION BETWEEN POLYMORPHISMS RELATED TO THE HYPOXIA PATHWAY AND TYPE 2 DIABETES MELLITUS
University of Cordoba, Spain; Reina Sofia University Hospital, Cordoba, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Multicellular organisms require a good oxygen homeostasis for survival. Within the hypoxia pathway, the major regulator is the transcription factor (HIF-1Ã?±), which regulates homeostasis and plays a very important role in various diseases. Previous studies have reported the importance of this transcription factor (HIF-1Ã?±) in controlling the most important stages of development of Type 2 Diabetes mellitus (T2DM) and metabolic syndrome (MetS), such as insulin resistance, Ã?²-cell dysfunction and finally, adipocyte dysfunction and inflammation. These results could be interesting in analyzing the hypoxia response pathway to find out new predictive biomarkers for these diseases. Prolyl-hydroxylases proteins (PHDs) and one of the ubiquitin-ligases responsible for its regulation, SIAH2 protein, stand out for their importance. In this report, we analyzed the presence of SNPs (Single Nucleotide Polymorphism) in proteins related to the hypoxia pathway associated with the risk of development of diabetes. We studied different SNPs that directly affect functional sites of the proteins related to this pathway. Therefore, we analyzed the impact of these in CORDIOPREV cohort, 989 patients who have suffered a cardiovascular event. Within this cohort, we analyzed a new group of patients who had developed diabetes in the last 5 years after suffering from a cardiovascular event. This cohort was compared to 160 healthy patients and a genotyping was done where their allelic frequency was studied. Four SNPs related to the hypoxia pathway associated with the risk of development of diabetes were identified. Two additional SNPs have been found to be related to metabolic syndrome. Another two could be involved in cardiovascular disease risk augmentation.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pancreatic Disorders & Therapy.
Short communication · 27 May 2026
Immunometabolic Interactions in Pancreatic Disease: Crosstalk Between Energy Dysregulation, Immune Activation, and Tissue Dysfunction
Commentary · 27 May 2026
Microvascular Dysfunction in Pancreatic Disorders: Endothelial Injury, Perfusion Failure, and Tissue Consequences
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPancreatic Disorders & Therapy
- SubjectGastroenterology & Hepatology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Jimenez Jimenez C”
- BylineArticles whose byline prints “Rangel Zuniga OA”
- BylineArticles whose byline prints “Lara Chica M”
- BylineArticles whose byline prints “Morrugares R”
- BylineArticles whose byline prints “Munoz E”
- BylineArticles whose byline prints “Lopez Miranda J”
- BylineArticles whose byline prints “Calzado M”
